On 26 July 2024, Xunfei Healthcare (讯飞医疗科技), also known as iFlyHealth), a medical artificial intelligence startup, filed a new prospectus with the Hong Kong Stock Exchange.

According to the prospectus, iFlyHealth ranks #1 in the healthcare AI industry in China (in terms of revenue).

China Merchants China Direct Investments (CMCDI 133 HK) owns 3.4% stake in iFlyHealth, which accounts for 5.3% of CMCDI’s total assets.

We, Argyle Street Management, hope there will be soaring demand for iFlyHealth IPO shares.

Chat with us on WeChat or Whatsapp:

💬 WeChat ID: ASM_Argyle

💬 WhatsApp ID: +852 6317 6371

🖥️ UnlockValueChinaMerchants.com

📧 ChinaMerchants@asmhk.com


2024年7月26日,讯飞医疗(iFlyHealth), 一家医疗人工智能初创公司,向港交所提交了新的招股说明书

根据招股说明书,讯飞医疗在中国医疗人工智能行业中排名第一(以收入计算)。

招股说明书显示,招商局中国基金(133 HK)持有讯飞医疗的3.4%股份,占到中国基金总资产的5.3%

我们,Argyle Street Management, ,祝愿讯飞医疗取得辉煌成就。

欢迎与我们联系:

💬 微信: ASM_Argyle

💬 WhatsApp ID: +852 6317 6371

🖥️ UnlockValueChinaMerchants.com

📧 ChinaMerchants@asmhk.com

Leave a comment